New Senior Shareholders Approve $2.3B Ventas Acquisition: Report

This acquisition comes at a time when every health system across the country is grappling with mounting financial pressures in what has been the most financially difficult year since the start of the pandemic coupled with labor shortages, staff burnout, rising patient demand and ongoing capacity challenges.

Greenberg Traurig acted as legal advisor to Grovecourt, and Capitala Group and Siguler Guff provided financing for the transaction.

The company started 2023 with $820 million in liquidity and has an eye on long-term growth.